[
    [
        {
            "time": "",
            "original_text": "逾四成A股上市药企销售费用同比增长复星医药广告宣传砸钱最猛",
            "features": {
                "keywords": [
                    "A股",
                    "药企",
                    "销售费用",
                    "同比增长",
                    "复星医药",
                    "广告宣传"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "逾四成A股上市药企销售费用同比增长复星医药广告宣传砸钱最猛",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "医药行业2020年年报及2021年一季报总结：Q1业绩复苏回暖看好CXO、疫苗、创新器械和服务等高景气板块",
            "features": {
                "keywords": [
                    "医药行业",
                    "年报",
                    "一季报",
                    "Q1业绩",
                    "复苏回暖",
                    "CXO",
                    "疫苗",
                    "创新器械",
                    "服务",
                    "高景气板块"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药行业2020年年报及2021年一季报总结：Q1业绩复苏回暖看好CXO、疫苗、创新器械和服务等高景气板块",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "【异动股】上海医药(02607.HK)跌3.06%",
            "features": {
                "keywords": [
                    "异动股",
                    "上海医药",
                    "下跌",
                    "3.06%"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "【异动股】上海医药(02607.HK)跌3.06%",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 7,
                "Duration": 4,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        }
    ]
]